Скайризи Рисанкизумаб 150 mg one Шприц ручка Abbive Risankizumab (brand name Skyrizi) is an interleukin-23 antagonist used to treat several immune-mediated inflammatory diseases. For detailed prescribing guidelines
Skyrizi ( risankizumab) 150 mg/ ml 1 syringe, Abbive, USA
Article:
In Stock
Risankizumab (brand name Skyrizi) is an interleukin-23 antagonist used to treat several immune-mediated inflammatory diseases. For detailed prescribing guidelines
- Commercial name:Скайризи
- Сhemical name:Рисанкизумаб
- Dosage:150 mg
- Quantity:one
- Release form:Шприц ручка
- Виробник:Abbive
No reviews yet